OrthoPediatrics Corp. (NASDAQ:KIDS) is set to announce third quarter earning results on Wednesday 4th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, KIDS to report 3Q20 loss of $ 0.31 per share.
For the full year, analysts anticipate top line of $ 70.51 million, while looking forward to loss of $ 1.46 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 88.51 million ~ $ 89.96 million
Click Here For More Historical Outlooks Of OrthoPediatrics Corp.
Previous Quarter Performance
OrthoPediatrics Corp. unveiled loss for the second quarter of $ 0.54 per share, from the revenue of $ 13.59 million. According to street consensus, KIDS was expected to report 2Q20 loss of $ 0.38 per share from revenue of $ 11.43 million. The bottom line results missed street analysts by $ 0.16 or 42.11 percent, at the same time, top line results outshined analysts by $ 2.16 million or 18.90 percent.
Stock Performance
Shares of OrthoPediatrics Corp. traded up $ 1.66 or 3.79 percent on Tuesday, reaching $ 45.44 with volume of 152.60 thousand shares. OrthoPediatrics Corp. has traded high as $ 45.68 and has cracked $ 44.34 on the downward trend
According to the previous trading day, closing price of $ 45.44, representing a 35.92 % increase from the 52 week low of $ 32.21 and a 21.79 % decrease over the 52 week high of $ 55.98.
The company has a market capital of $ 888.32 million and is part of the Healthcare sector and Medical Devices industry.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The companys products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard. It offers trauma and deformity procedures; scoliosis procedures for the treatment of spinal deformity; and sports medicine procedures.
